BIO-TECHNE Corp — Director's Dealing 2016

Oct 31, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-10-27

Reporting Person: HIGGINS JOHN L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-27	Common Stock	A	914	—	Acquired	2273	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-27	Stock Option (right to buy)	$101.19	A	3985	Acquired	2026-10-26	Common Stock (3985)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$87.34	2025-10-28	Common Stock (4260)	4260	Direct
Stock Option (right to buy)	$91.78	2024-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$87.39	2023-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$66.90	2022-10-24	CommonS tock (5000)	5000	Direct
Stock Option (right to buy)	$70.35	2021-10-26	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$61.46	2020-10-27	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$63.03	2019-10-28	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$61.08	2019-05-19	Common Stock (10000)	10000	Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.